financetom
Business
financetom
/
Business
/
Flex Insider Sold Shares Worth $5,034,765, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Flex Insider Sold Shares Worth $5,034,765, According to a Recent SEC Filing
May 26, 2025 5:37 AM

03:24 AM EDT, 05/12/2025 (MT Newswires) -- Revathi Advaithi, Director, Chief Executive Officer, on May 07, 2025, sold 132,000 shares in Flex (FLEX) for $5,034,765. Following the Form 4 filing with the SEC, Advaithi has control over a total of 1,100,473 ordinary shares of the company, with 1,100,473 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/866374/000162828025024414/xslF345X05/wk-form4_1746837410.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
United jet suffered navigation parts failure before injury incident
United jet suffered navigation parts failure before injury incident
Mar 18, 2025
WASHINGTON (Reuters) - A United Airlines Boeing 787 jetliner on a January 24 flight bound for Washington from Lagos suffered a failure of two key parts for navigation before a sudden unexpected aircraft movement led to passenger injuries, investigators said. The National Transportation Safety Board said the left and then right inertial reference units failed, which was followed by the...
IonQ Unusual Options Activity
IonQ Unusual Options Activity
Mar 18, 2025
Deep-pocketed investors have adopted a bearish approach towards IonQ ( IONQ ) , and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in IONQ ( IONQ ) usually suggests something big is about to happen. We gleaned...
Sarepta Therapeutics Says Patient Dies After Elevidys Gene Therapy for Duchenne Muscular Dystrophy; Shares Fall
Sarepta Therapeutics Says Patient Dies After Elevidys Gene Therapy for Duchenne Muscular Dystrophy; Shares Fall
Mar 18, 2025
02:37 PM EDT, 03/18/2025 (MT Newswires) -- Sarepta Therapeutics ( SRPT ) shares were down nearly 23% in recent Tuesday trading after the biopharmaceutical company said a young patient with Duchenne muscular dystrophy passed away due to acute liver failure following treatment with its Elevidys gene therapy. Acute liver injury, including failure, is a known side effect of Elevidys and...
Aditxt Shares Up After Acquisition Target Appili Files Funding Plans
Aditxt Shares Up After Acquisition Target Appili Files Funding Plans
Mar 18, 2025
02:46 PM EDT, 03/18/2025 (MT Newswires) -- Aditxt ( ADTX ) shares were up over 57% in recent Tuesday trading after its acquisition target, Appili Therapeutics, submitted four new federal funding proposals totaling $117.5 million. The largest funding proposal seeks $46.3 million to develop a vaccine against invasive fungal infections from the National Institute of Allergy and Infectious Diseases, Appili...
Copyright 2023-2026 - www.financetom.com All Rights Reserved